Correlation Between VistaGen Therapeutics and COSCIENS Biopharma
Can any of the company-specific risk be diversified away by investing in both VistaGen Therapeutics and COSCIENS Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VistaGen Therapeutics and COSCIENS Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VistaGen Therapeutics and COSCIENS Biopharma, you can compare the effects of market volatilities on VistaGen Therapeutics and COSCIENS Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VistaGen Therapeutics with a short position of COSCIENS Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of VistaGen Therapeutics and COSCIENS Biopharma.
Diversification Opportunities for VistaGen Therapeutics and COSCIENS Biopharma
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between VistaGen and COSCIENS is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding VistaGen Therapeutics and COSCIENS Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSCIENS Biopharma and VistaGen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VistaGen Therapeutics are associated (or correlated) with COSCIENS Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSCIENS Biopharma has no effect on the direction of VistaGen Therapeutics i.e., VistaGen Therapeutics and COSCIENS Biopharma go up and down completely randomly.
Pair Corralation between VistaGen Therapeutics and COSCIENS Biopharma
Given the investment horizon of 90 days VistaGen Therapeutics is expected to generate 0.71 times more return on investment than COSCIENS Biopharma. However, VistaGen Therapeutics is 1.42 times less risky than COSCIENS Biopharma. It trades about -0.19 of its potential returns per unit of risk. COSCIENS Biopharma is currently generating about -0.26 per unit of risk. If you would invest 322.00 in VistaGen Therapeutics on September 4, 2024 and sell it today you would lose (39.00) from holding VistaGen Therapeutics or give up 12.11% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
VistaGen Therapeutics vs. COSCIENS Biopharma
Performance |
| Timeline |
| VistaGen Therapeutics |
| COSCIENS Biopharma |
VistaGen Therapeutics and COSCIENS Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with VistaGen Therapeutics and COSCIENS Biopharma
The main advantage of trading using opposite VistaGen Therapeutics and COSCIENS Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VistaGen Therapeutics position performs unexpectedly, COSCIENS Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSCIENS Biopharma will offset losses from the drop in COSCIENS Biopharma's long position.| VistaGen Therapeutics vs. Candel Therapeutics | VistaGen Therapeutics vs. Cingulate Warrants | VistaGen Therapeutics vs. Unicycive Therapeutics | VistaGen Therapeutics vs. Cardio Diagnostics Holdings |
| COSCIENS Biopharma vs. Candel Therapeutics | COSCIENS Biopharma vs. Cingulate Warrants | COSCIENS Biopharma vs. Unicycive Therapeutics | COSCIENS Biopharma vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |